A retrospective study: Long term prognosis in adults with PA-VSD-MAPCAs

IF 4.3 3区 材料科学 Q1 ENGINEERING, ELECTRICAL & ELECTRONIC
Sophie Berghmans , Bénédicte Eyskens , Filip Rega , Philip Moons , Els Troost , Pieter De Meester , Alexander Van De Bruaene , Werner Budts
{"title":"A retrospective study: Long term prognosis in adults with PA-VSD-MAPCAs","authors":"Sophie Berghmans ,&nbsp;Bénédicte Eyskens ,&nbsp;Filip Rega ,&nbsp;Philip Moons ,&nbsp;Els Troost ,&nbsp;Pieter De Meester ,&nbsp;Alexander Van De Bruaene ,&nbsp;Werner Budts","doi":"10.1016/j.ijcard.2024.132476","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Pulmonary Atresia, Ventricular Deptal Defect, and Major Aortopulmonary Collateral Arteries (PA-VSD-MAPCAs) is a congenital cyanotic heart defect with poor prognosis. Due to its complex and highly variable anatomy, the best treatment plan is not clear. We aimed (1) to investigate the survival of PA-VSD-MAPCAs patients according to the underlying original anatomy and treatment strategy, and (2) to evaluate life expectancy between patients with or without severe hypoplastic native pulmonary arteries (NPAs) after surgical versus non-surgical treatment.</p></div><div><h3>Methods</h3><p>A prospectively established database of 169 PA-VSD-MAPCAs patients treated and followed up at University Hospitals Leuven was accessed. Patients were divided into three groups according to the treatment strategy. Kaplan-Meier survival curves were plotted, and Log Rank tests were used for comparison.</p></div><div><h3>Results</h3><p>The overall mean survival for patients with PA-VSD-MAPCAs was 38.5 years (95%-CI: 33.1–43.9). Patients with complete intracardiac repair had the longest mean survival of 43.8 years (95%-CI: 38.1–49.6) versus the other groups (<em>p</em> &lt; 0.001). A longer mean event-free survival time was found in patients with normal, well-developed NPAs (<em>p</em> = 0.047). Finally, patients with poorly developed or absent NPAs had worse survival rates when a surgical approach was followed. Systemic-pulmonary shunt placement or unifocalisation had limited effect on prognosis in the absence of total repair (<em>p</em> = 0.167).</p></div><div><h3>Conclusions</h3><p>Patients with PA-VSD-MAPCAs who underwent complete intracardiac repair and/or with well-developed native pulmonary arteries had the best prognosis. Our analyzed data suggest that incomplete surgical repair resulted in survival rates comparable to those seen with a non-surgical approach.</p></div>","PeriodicalId":3,"journal":{"name":"ACS Applied Electronic Materials","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Electronic Materials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0167527324010982","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, ELECTRICAL & ELECTRONIC","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Pulmonary Atresia, Ventricular Deptal Defect, and Major Aortopulmonary Collateral Arteries (PA-VSD-MAPCAs) is a congenital cyanotic heart defect with poor prognosis. Due to its complex and highly variable anatomy, the best treatment plan is not clear. We aimed (1) to investigate the survival of PA-VSD-MAPCAs patients according to the underlying original anatomy and treatment strategy, and (2) to evaluate life expectancy between patients with or without severe hypoplastic native pulmonary arteries (NPAs) after surgical versus non-surgical treatment.

Methods

A prospectively established database of 169 PA-VSD-MAPCAs patients treated and followed up at University Hospitals Leuven was accessed. Patients were divided into three groups according to the treatment strategy. Kaplan-Meier survival curves were plotted, and Log Rank tests were used for comparison.

Results

The overall mean survival for patients with PA-VSD-MAPCAs was 38.5 years (95%-CI: 33.1–43.9). Patients with complete intracardiac repair had the longest mean survival of 43.8 years (95%-CI: 38.1–49.6) versus the other groups (p < 0.001). A longer mean event-free survival time was found in patients with normal, well-developed NPAs (p = 0.047). Finally, patients with poorly developed or absent NPAs had worse survival rates when a surgical approach was followed. Systemic-pulmonary shunt placement or unifocalisation had limited effect on prognosis in the absence of total repair (p = 0.167).

Conclusions

Patients with PA-VSD-MAPCAs who underwent complete intracardiac repair and/or with well-developed native pulmonary arteries had the best prognosis. Our analyzed data suggest that incomplete surgical repair resulted in survival rates comparable to those seen with a non-surgical approach.

一项回顾性研究:患有 PA-VSD-MAPCAs 的成人的长期预后。
背景:肺动脉闭锁、室部缺损和大动脉-肺动脉侧支(PA-VSD-MAPCAs)是一种预后不良的先天性紫绀型心脏缺陷。由于其复杂多变的解剖结构,最佳治疗方案尚不明确。我们的目的是:(1) 根据基本的原始解剖结构和治疗策略,研究 PA-VSD-MAPCAs 患者的存活率;(2) 评估有或无严重原发性肺动脉发育不良的患者在手术与非手术治疗后的预期寿命:方法:访问了鲁汶大学医院治疗和随访的 169 名 PA-VSD-MAPCAs 患者的前瞻性数据库。根据治疗策略将患者分为三组。绘制了 Kaplan-Meier 生存曲线,并使用 Log Rank 检验进行比较:结果:PA-VSD-MAPCA 患者的总平均生存期为 38.5 年(95%-CI:33.1-43.9 年)。与其他组别相比,完全心内修复的患者平均存活时间最长,为 43.8 年(95%-CI:38.1-49.6 年)(P 结论:PA-VSD-MAPCA 患者的平均存活时间最长,为 43.8 年(95%-CI:38.1-49.6 年):接受了完整心内修复术和/或原生肺动脉发育良好的 PA-VSD-MAPCA 患者预后最好。我们的分析数据表明,不完全手术修复的存活率与非手术方法的存活率相当。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.20
自引率
4.30%
发文量
567
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信